High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy (Q47225234)

http://europepmc.org/abstract/MED/29309059

12 January 2018

title

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy (English)

1 reference

http://europepmc.org/abstract/MED/29309059

12 January 2018

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Carsten Krieg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sabrina A Schindler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Felix J Hartmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Lukas M Weber

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Mitchell P Levesque

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Burkhard Becher

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Roksana Iwanicka-Nowicka

2

object named as

Malgorzata Nowicka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

3

Silvia Guglietta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

7

Reinhard Dummer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

English

0 references

publication date

8 January 2018

1 reference

http://europepmc.org/abstract/MED/29309059

12 January 2018

published in

Nature Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

144-153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm.4466

2 June 2020

exact match

0 references

cites work

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

1 reference

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

21 January 2018

1 reference

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

21 January 2018

1 reference

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

21 January 2018

1 reference

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

21 January 2018

1 reference

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

21 January 2018

1 reference

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

21 January 2018

1 reference

Monitoring immune-checkpoint blockade: response evaluation and biomarker development

21 January 2018

1 reference

Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients

21 January 2018

1 reference

Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring

21 January 2018

1 reference

Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis

21 January 2018

1 reference

FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data

21 January 2018

1 reference

Comparison of clustering methods for high-dimensional single-cell flow and mass cytometry data.

21 January 2018

1 reference

CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets.

21 January 2018

1 reference

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

21 January 2018

1 reference

Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.

21 January 2018

1 reference

Sensitive detection of rare disease-associated cell subsets via representation learning.

21 January 2018

1 reference

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

21 January 2018

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

21 January 2018

1 reference

Pembrolizumab versus Ipilimumab in Advanced Melanoma

21 January 2018

1 reference

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

21 January 2018

1 reference

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

21 January 2018

1 reference

Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

21 January 2018

1 reference

Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.

21 January 2018

1 reference

Clinical significance of macrophage heterogeneity in human malignant tumors

21 January 2018

1 reference

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

21 January 2018

1 reference

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

21 January 2018

1 reference

Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity

21 January 2018

1 reference

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

21 January 2018

1 reference

Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression

21 January 2018

1 reference

Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma.

21 January 2018

1 reference

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

21 January 2018

1 reference

Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites

21 January 2018

1 reference

Homing and cellular traffic in lymph nodes

21 January 2018

1 reference

Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation

21 January 2018

1 reference

Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment

21 January 2018

1 reference

High-dimensional single-cell analysis reveals the immune signature of narcolepsy.

21 January 2018

1 reference

Normalization of mass cytometry data with bead standards

21 January 2018

1 reference

Salmon provides fast and bias-aware quantification of transcript expression

21 January 2018

1 reference

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

21 January 2018

1 reference

Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation

21 January 2018

1 reference

Use FlowRepository to Share Your Clinical Data upon Study Publication.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Interferon-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29309059

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29309059

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.4466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29309059%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference